Nephros, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 05/15/2025 | 3.60 M | $6.19 M | 0.00% | 33.97% |
| TOPLINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 422.09 K | $725.99 K | 0.52% | 3.98% |
| VANGUARD GROUP INC | 05/09/2025 | 204.16 K | $351.15 K | 1.07% | 1.93% |
| BARD ASSOCIATES INC | 05/12/2025 | 143.22 K | $246.34 K | -7.76% | 1.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 90.29 K | $155.34 K | 6.41% | 0.85% |
| HIGHTOWER ADVISORS, LLC | 05/13/2025 | 55.71 K | $95.82 K | 0.00% | 0.53% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 38.92 K | $67.00 K | -6.05% | 0.37% |
| BLAIR WILLIAM & CO/IL | 05/09/2025 | 36.25 K | $62.35 K | 0.00% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 23.62 K | $40.62 K | -0.77% | 0.22% |
| STATE STREET CORP | 05/15/2025 | 15.70 K | $27.00 K | 0.00% | 0.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 05/08/2025 | 13.80 K | $23.74 K | 0.00% | 0.13% |
| CITADEL ADVISORS LLC | 05/15/2025 | 12.02 K | $20.68 K | -15.85% | 0.11% |
| MORGAN STANLEY | 05/15/2025 | 5.42 K | $9.33 K | 0.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.80 K | $4.81 K | 7.66% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 79 | $136 | 3.95% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 31 | $52 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 13 | $22 | -13.33% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nephros, Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Nephros, Inc.. The most heavily invested institutionals were:
WEXFORD CAPITAL LP: 3.6 M
Topline Capital Management, LLC: 422,089
VANGUARD GROUP INC: 204,158
BARD ASSOCIATES INC: 143,221
GEODE CAPITAL MANAGEMENT, LLC: 90,289
HighTower Advisors, LLC: 55,710
44.00% of Nephros, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.29 M shares in the last 24 months. This purchase volume represents approximately $20.42 M in transactions.